//////

AGENDA

c4b71f04-225c-4f20-99c3-70873e434a13

Virtual media briefing

18:00 - 19:30 CEST
12:00 - 13:30 EST
Thursday, September 10, 2020

 

SESSION TITLE

SPEAKERS

Opening and welcome

Dr. Kirhan Ozgurdal, Global Medical Affairs Physician – Oncology, Bayer

Importance of improving survival in patients with unresectable HCC

Dr. Catherine Frenette, Scripps Green Hospital, USA

Changing treatment landscape and importance of systemic therapy sequencing

Prof. Peter Galle, University Medical Center Mainz, Germany

Effective treatment and management plan to improve survival in HCC

Dr. Richard Finn, UCLA Medical Center, USA

Facilitated Q&A

Dr. Catherine Frenette, Prof. Richard Finn, Prof. Peter Galle, Prof. Jean-Frédéric Blanc, Le Centre Hospitalier Universitaire de Bordeaux, France

Summary and close

Dr. Catherine Frenette

Opportunity for 1:1 interviews with panellists

Dr. Catherine Frenette and Dr. Richard Finn, USA Prof. Peter Galle, Germany, Prof. Jean-Frédéric Blanc, France